...
首页> 外文期刊>Journal of International Medical Research >Irreversible profound symptomatic bradycardia requiring pacemaker after tizanidine/loxoprofen combination therapy: a case report
【24h】

Irreversible profound symptomatic bradycardia requiring pacemaker after tizanidine/loxoprofen combination therapy: a case report

机译:替扎尼定/洛索洛芬联合治疗后需要起搏器的不可逆性严重症状性心动过缓:一例报告

获取原文
           

摘要

A 37-year-old man suffered irreversible profound symptomatic bradycardia requiring a pacemaker 3 days after beginning tizanidine/loxoprofen combination therapy for neck pain. This combination therapy is prescribed frequently for joint pain; however, combining loxoprofen with tizanidine could increase the risk of symptomatic bradycardia that is both permanent and severe. Similar cases have not been reported. This case suggests that tizanidine should be used cautiously when combined with loxoprofen, and drug interaction screening should be performed.
机译:一名37岁的男子患有不可逆转的严重症状性心动过缓,在开始使用替扎尼定/洛索洛芬治疗颈部疼痛3天后,需要起搏器。经常为关节痛开这种联合疗法。但是,将洛索洛芬与替扎尼定合用会增加永久性和严重症状性心动过缓的风险。尚未报告类似病例。该病例提示与洛索洛芬联用时应谨慎使用替扎尼定,并应进行药物相互作用筛选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号